diabetestalk.net

Medtronic Returns Address

The Surprising Reason For Medtronic's Disappointing Diabetes Sales

The Surprising Reason For Medtronic's Disappointing Diabetes Sales

The Surprising Reason for Medtronic's Disappointing Diabetes Sales Medtronic secured early FDA approval for its MiniMed 670G, the closest step toward an artificial pancreas for patients with diabetes, during its last fiscal quarter. So why were diabetes sales below expectations? In its quarterly earnings report Tuesday morning, Medtronic reported sales that missed analyst expectations, notably in the Diabetes as well as Cardiac and Vascular Group businesses. At first glance, the shortfall in the Diabetes business may seem odd given the regulatory victory during the quarter-- early FDA approval of the MiniMed 670G insulin pump . In reality, it seems that the light diabetes revenue may have been because of--not despite--the early FDA win. Medtronic reported diabetes sale of $462 million for its second quarter of fiscal 2017, $24 million below Wall Street's consensus estimate of $486 million. In slides presented alongside its November 22 earnings call, Medtronic pointed out that US. sales of its insulin pumps were negatively impacted as consumers anticipated the new device launch. The670G system commercial launch is anticipated in spring 2017. According to a Seeking Alpha transcript of the earnings call, Omar Ishrak, Medtronic chairman and CEO, said, "We were pleased with the earlier than expected FDA approval of the MiniMed 670G . . . however, the earlier than expected approval has created a bigger than expected gap between product approval and shipment." The 670Gsystem has theSmartGuardHCLalgorithm and seven-day Guardian Sensor, which is more accurate than the company's earlier sensors. While patients do need to input mealtime carbohydrates, calibrate the sensor, and accept bolus correction recommendations, the algorithm is intended to keep patients within their target Continue reading >>

J.p. Morgan Breaking News: Medtronic, Inc. To Return 50% Of Cash Flow To Shareholders, Will Close Covidien Deal In Weeks

J.p. Morgan Breaking News: Medtronic, Inc. To Return 50% Of Cash Flow To Shareholders, Will Close Covidien Deal In Weeks

J.P. Morgan Breaking News: Medtronic, Inc. to Return 50% of Cash Flow to Shareholders, Will Close Covidien Deal in Weeks By Riley McDermid , BioSpace.com Breaking News Sr. Editor Medical technology firm Medtronic delighted investors Monday, saying during a presentation that it would be using its significant cash flow to reward shareholders by returning as much as 50 percent of it via share buybacks and Medtronic also could not say enough about its recent acquisition of device marker Covidien , saying that deal will close in the last week of January or early February and will meaningfully accelerate the companys main three strategies of therapy innovation, globalization and economic value. Medtronic made the announcement at the J.P. Morgan Healthcare Conference which begins Monday in San Francisco and the oldest and largest conference of its type. It will include 300 of the largest biotech, healthcare and biopharma companies presenting their top-line data and estimates to a sea of eager bankers, analysts, institutional investors, hedge funds and journalists. Chairman and CEO Omar Ishrak said during his presentation that those three areas are crucial to Medtronics calculus going forward in 2015. "We are steadfast in our focus on delivering long-term value in healthcare and believe there is significant growth opportunity for us as our strategies address the three universal healthcare needs: improving clinical outcomes, expanding access, and optimizing cost and efficiency," said Ishrak. "Aligned with these universal healthcare needs, our three key strategies will deliver new therapies, unlock opportunities in emerging markets and develop new solutions for hospital efficiency and disease management. Outside of Covidien, the companys biggest news was its potential cash boon Continue reading >>

Omar Ishrak, Head Of Medtronic, Outlines Strategy - The New York Times

Omar Ishrak, Head Of Medtronic, Outlines Strategy - The New York Times

Business Day |Medtronics New Leader Outlines Growth Strategy Medtronics New Leader Outlines Growth Strategy The new chief executive of Medtronic , the worlds largest medical device maker, vowed on Tuesday to revive the companys growth by further expanding it internationally and improving its returns from research spending. Omar Ishrak, who took over the company in June, said Medtronic remained committed to returning cash to shareholders and to exploring smaller acquisitions. He also said he planned no major changes to the companys diversified portfolio of medical devices except for the planned sale or spinoff of its external defibrillator business. Mr. Ishraks comments, made on the companys fiscal first-quarter conference call, gave the first glimpse of his strategy since he took over. The company reported quarterly results that met analysts estimates. Net income in its fiscal first quarter, which ended July 29, was $821 million, compared with $830 million during the same period a year ago. Revenue in the quarter rose to $4.05 billion, 7.3 percent higher than the same period a year earlier. Analysts had expected $3.98 billion. From the point of view of setting the stage, I think he did a pretty good job, said Jan Wald, an analyst at Morgan Keegan & Company. He came across as sort of a tough guy, one who is going to be relentless in his pursuit of data and execution, he said. Medtronic is struggling with weak demand and pricing in its important markets for heart defibrillators and spine products. In part, the slow demand is the result of a weak economy. But a study suggesting that heart devices are improperly used in patients who are too sick for them, and accusations in a medical journal that researchers hid serious complications with the companys Infuse bone growth pr Continue reading >>

How To Return Recalled Medtronic Minimed Infusion Sets Information For Pharmacists And Health Professionals

How To Return Recalled Medtronic Minimed Infusion Sets Information For Pharmacists And Health Professionals

How to Return Recalled Medtronic MiniMed Infusion Sets information for pharmacists and health professionals How to Return Recalled Medtronic MiniMed Infusion Sets information for pharmacists and health professionals Following the recent urgent recall of the Medtronic infusion sets, Medtronic has updated the instructions for pharmacists and healthcare professionals about how to have the recalled infusion sets replaced. This recall was initiated following recent reports of the potential over-delivery of insulin shortly after an infusion set change. You can find more information about the recalled Medtronic infusion sets here . To receive replacements for recalled infusion sets in, you can visit and follow the instructions on the website. The site can be used by all pump users, pharmacies and healthcare professionals. The website will prompt you to enter the REF and LOT numbers for the infusion sets. You will then be told which of the infusion sets are included in the recall, and which are not. When submitting your request for replacement infusion sets you will be asked to complete the Pump Serial Number field. For pharmacists submitting requests for replacement infusion sets, select PHM for the Pump Serial Number field. If you have previously checked lots and now want to order replacements, please make sure you clear your cache on your web browser before completing the online form. Healthcare professionals will need to select HCP in this field. To ensure that your replacement request is processed, make sure you click the SUBMIT button once your form is complete. Once the online form is submitted, replacement box/es of infusion sets will be sent by Medtronic directly to your nominated delivery address, free of charge. Please cut-out and retain the barcodes on your recalle Continue reading >>

Medtronic

Medtronic

From the dashboard, go to My Profile . On the Accounts tab, select the account you wish to modify. You can then select default ship to and/or bill to locations. If you are a site administrator and you do not see the account or location you need, use the Request Account Data Modification form to submit a request to Medtronic to make the necessary changes to your account. If you are not a site administrator, go to My Profile and use the Request Profile Change form to submit a request to your site administrator for review and approval. What is the difference between the administrator, purchaser and viewer roles? Administrator - responsible for new user creation, assigning user roles and verifying/approving account access. Purchaser - allows for order creation, access to current pricing, view order history, track shipments and print invoice copies. Viewer - allows access to view order history, track shipments, and print invoice copies. You can view the status of recent web orders for the active facility from the View Orders tab on My Dashboard . You can also click on View Complete Order History from the dashboard to see the status of all orders for the active facility. To view order status by line item, go to Order Details by either locating the order in the View Complete Order History list or by entering a search term. Within Order Details, click the + sign next to each item to view the status. Locate the order in the View Complete Order History list or enter a search term from the View Orders tab on My Dashboard . Within Order Details, click the + sign next to the items you wish to track. Tracking online is only available for orders placed through the portal. If an order is placed via another channel please contact Customer Services. The product may not be available on m Continue reading >>

Lobbying Organisation | Lobbying.ie

Lobbying Organisation | Lobbying.ie

Date of registration {{Lobbyist.CreatedDate | date : 'd MMMM, yyyy' }} Date last updated {{Lobbyist.Timestamp | date : 'd MMMM, yyyy'}} Contact phone number {{Lobbyist.Phone || "N/A"}} Organisation Website {{Lobbyist.Website || "N/A"}} {{Lobbyist.LobbyistActivity.Name || "N/A"}} ({{Lobbyist.LobbyistActivityOtherText}}) Company Registration Number {{Lobbyist.CompanyRegistrationNumber || "N/A"}} Company Registration Name {{Lobbyist.CompanyRegisteredName || "N/A"}} Company Registered Address {{Lobbyist.CompanyRegisteredAddress || "N/A"}} Registration details have changed during return period The Standards Commission receives hundreds of returns for each relevantdeadline. Returns submitted at the most recent deadline may take severalweeks to process and verify. If we notice any omissions or errors, we willcontact the registrant to revise and resubmit their return. Statistics for the relevant period reflect the total number of returns filed by subject matter. They do not reflect the volume or extent of lobbying activity conducted for each subject or within each return. Statistics for the relevant period reflect the total number of returns filed by subject matter. They do not reflect the volume or extent of lobbying activity conducted for each subject or within each return. Statistics for the relevant period reflect the total number of returns filed by subject matter. They do not reflect the volume or extent of lobbying activity conducted for each subject or within each return. Statistics for the relevant period reflect the total number of returns filed by subject matter. They do not reflect the volume or extent of lobbying activity conducted for each subject or within each return. Continue reading >>

Medtronic Launching Stand-alone Cgm: Guardian Connect

Medtronic Launching Stand-alone Cgm: Guardian Connect

We're sorry, an error occurred. We are unable to collect your feedback at this time. However, your feedback is important to us. Please try again later. For the first time in a decade, people with diabetes in the U.S. who are not using an insulin pump can get a stand-alone continuous glucose monitor (CGM) from Medtronic Diabetes. The company announced Monday that it had received FDA approval on March 8 for its Guardian Connect system, after regulators spent two years (!) reviewing this smartphone-compatible medical device that's been on the market overseas since 2016. We've got a rundown of the product specs below. But in a nutshell, the new Guardian Connect marks Medtronic's return to the stand-alone CGM market, a shift from its aggressive marketing in recent years pushing customers to purchase an insulin pump-CGM combo system. While it uses the same Guardian 3 sensor approved for use with the Minimed 670G hybrid closed loop system, this new stand-alone CGM has a different transmitter with built-in Bluetooth Low Energy (aka Bluetooth 4.0). That allows the transmitter to share data directly with a smartphone, notably bypassing the need for a separate dedicated receiver device. This is a first for the FDA and is probably the reason it took two years of consideration before approval. As the first so-called "smart CGM" that needs a smartphone and mobile app to function, this could re-shape the conversation on insurance and Medicare coverage for diabetes tech tools, as it makes the smartphone a necessity, rather than an optional extra. The last stand-alone CGM that MedT offered was the Guardian Real-Time system in 2007, and about six years ago they also launched the mySentry display monitor with limited-range data sharing capabilities. Since then, the company's been leading Continue reading >>

Medtronic Counsel Returns To Oppenheimer Wolff

Medtronic Counsel Returns To Oppenheimer Wolff

Medtronic Counsel Returns To Oppenheimer Wolff Law360 (February 17, 2009, 12:00 AM EST) -- Former principal litigation counsel for medical device maker Medtronic Inc . Michael Vanselow has returned to Minneapolis-based Oppenheimer Wolff & Donnelly LLP s health care litigation practice as a partner, after leaving the firm 18 years ago to work for the Minnesota Attorney Generals Office . Vanselow, who served as principal litigation counsel at Medtronic for the past two years, told Law360 that he returned to private practice in order to restore direct litigation to the center of his practice. My passion lies more with being a litigator on the front lines, Vanselow said. At Medtronic, Vanselow managed the companys headline-grabbing mass tort product liability litigation as well as employment- and insurance-related litigation. He also oversaw the companys response to government health law investigations. While hiring outside counsel to handle direct litigation, Vanselow said, I found myself thinking I wanted to do the job of the lawyers I was hiring. Returning to his old stomping grounds at Oppenheimer appealed to him not only because the firm has an impressive group of attorneys, Vanselow said, but also because he liked the opportunity his former colleagues offered him to help with future expansion of the firms health care litigation practice. Vanselow has come back to private practice with a unique perspective, having served as deputy attorney general for the state of Minnesota, and finally having gone in-house as corporate counsel at Medtronic. Vanselow said he believed his divergent types of legal experience would be invaluable to him in his new practice because his clients could benefit from his understanding of how government investigators think and from his sensitivi Continue reading >>

Medtronic Returns To Baker Communications For Exceptional Customer Service Training

Medtronic Returns To Baker Communications For Exceptional Customer Service Training

Medtronic Diabetes, a division of Medtronic, Inc. and leader of the technological curve in diabetes care, has requested that Baker Communications provide exceptional customer service skills training for its customer service teams. Medtronics sales department has benefited previously from Baker sales training seminars, and when a new training need arose in customer service, Medtronic returned to Baker in the full confidence that they have an outstanding training partner to help them attain their goals. An Exceptional Customer Service Training Expert and Senior Level Instructor with Baker Communications will travel to Minnesota to work with Medtronic customer service representatives. During this comprehensive customer service skills workshop , participants will gain practical experience using proven customer service strategies such as the 3 Fs Model (Handling Feelings, Finding Facts and Finding Solutions) to help them effectively diagnose and resolve customer issues. Attendees of the Exceptional Customer Service training workshop will also learn and practice using effective techniques such as Empathy and Active Listening to quickly establish rapport, communicating a sense of understanding and respect and cementing valuable customer relationships. Baker Communications designs and deploys Peak Performance and Transformation Solutions that ignite and sustain growth. As one of the fastest growing Performance Improvement companies in the world, Baker Communications delivers innovative products and services in eight areas including Sales, Marketing, CRM, Negotiations, Presentations, Management, Customer Service, and Time Management. Over 1,000 corporations per year, including 50% of the Fortune 500, partner with Baker Communications to improve the performance of their business Continue reading >>

Dividend Tax Treatment And Return Of Capital Basis Adjustments

Dividend Tax Treatment And Return Of Capital Basis Adjustments

Dividend Tax Treatment and Return of Capital Basis Adjustments Dividend Distribution U.S. Tax Treatment and Return of Capital (ROC) Basis Adjustments A portion of Medtronics dividends paid following the completion of the Covidien acquisition, starting with the dividend distribution paid on April 17, 2015, and ending with the dividend distribution paid April 16, 2016, were treated for U.S. tax purposes as a return of capital (ROC) instead of a distribution of earnings. Under applicable U.S. tax rules, dividend distributions treated as a ROC reduce a shareholders tax basis in the shares held, while dividend distributions treated as a distribution of earnings are characterized as ordinary income. The final determination of the portion of any particular dividend distribution treated as a ROC versus a distribution of earnings is reported by Medtronic on IRS Form 8937. Copies of Medtronics Form 8937 filings are posted to this page, below. The following table summarizes the Medtronic plc dividend distribution U.S. tax treatment for all dividends paid between April 17, 2015 and April 16, 2016. For complete information, please see the Form 8937s below. For questions regarding your specific situation, you should consult your tax and/or financial advisor. Please note, the dividend paid on January 15, 2015 was paid by Medtronic, Inc. and was a distribution of earnings. The above table assumes the Medtronic plc shareholder held Medtronic, Inc. shares purchased before the close of the Covidien acquisition, which occurred prior to the NYSE market open on January 26, 2015. The transaction close basis was $76.95 which reflects the Medtronic, Inc. closing share price from Friday, January 23, 2015. Any Medtronic plc shares owned as of the close of the Covidien acquisition on January 26, Continue reading >>

Medtronic Twin Cities Marathon Weekend Show Your Bib Campaign Returns For Racers

Medtronic Twin Cities Marathon Weekend Show Your Bib Campaign Returns For Racers

Medtronic Twin Cities Marathon Weekend Show Your Bib Campaign Returns for Racers Medtronic Twin Cities Marathon Weekend Show Your Bib Campaign Returns for Racers A new site highlights deals from 17 restaurants and breweries throughout the city of Saint Paul. Runners who show their race bib from any weekend event will find great food and beverage deals throughout the city from October 3-6, 2014. Adam Johnson, Vice President of Marketing & Communications C: 651.226.5403 | [email protected] Lisa Huber, Marketing & Media Relations Manager C: 612.396.3864 | [email protected] SAINT PAUL, Minn. Visit Saint Paul, the citys convention and visitors bureau, is welcoming runners in town for the Medtronic Twin Cities Marathon with a microsite at www.visitsaintpaul.com/bibs. The site highlights deals from 17 restaurants and breweries throughout the city of Saint Paul. Runners who show their race bib from any weekend event will find great food and beverage deals throughout the city from October 3-6, 2014. We are so excited to welcome the 28,000+ runners from all over the world to Saint Paul for the 33rd annual Medtronic Twin Cities Marathon Weekend, said Terry Mattson, President and CEO of Visit Saint Paul. After the success of last years Show Your Bib campaign, we decided to make it an annual campaign so that participants can explore the city through this fun promotion. A map and addresses of participant locations can be found at www.visitsaintpaul.com/bibs. Deals for runners include: Bennetts Chop and Railhouse: $4 off Bennetts Mac-n-Cheese on Friday | BOGO domestic tap beer Black Sheep Pizza: $3 Tap beer and house wine Burger Moes: One free pint of beer with burger purchase FACES Mears Park: BOGO FACES wine or tap beer, one per guest Great Waters Brewing Co.: $2. Continue reading >>

Medtronic Lack Of

Medtronic Lack Of "customer Service"

I've been a pump user for 17 years and I was unfortunate enough to be talked into trying a Medtronic pump for the first time. I guess using the word "trying" would be getting a little ahead of myself because I never made it that far. Medtronic is AWFUL. Calling their "customer support" for anything is a total waste of time. You'll be on the phone for a minimum of 30 minutes and your problem will absolutely not be resolved on the first try even if you are certain everything was taken care of. I know there isn't many choices left when it comes to insulin pumps but save yourself some aggravation and go with someone else! Moderator Type1 - Minimed 640G - Enlite CGM That is disappointing. Here in Australia I have found Metronic tech support excellent. I've never had to wait more than a couple of minutes to get through and though accents & fuzzy lines can making communication a bit difficult, I've always had my problem resolved. Having said that, were you trying to go through tech support to purchase a pump, or did you have a pump with a problem? If it was to organise purchase, I doubt tech support would be the right place to go. Can you get your DE to do the ground work for you? D.D. Family T1 since 1985, MM Pump 2013, CGM 2015 All I can tell you is that is 100% opposite of my experience with Medtronic the past 5 years. While calls can take some time (they are very thorough in documenting everything), I really can't recall them ever failing to resolve an issue with the first call. For instance, the end of last year I called because the little rubber bumper sticker on the end of my 530G had come off. I was just hoping they'd send me a new bumper to stick on, as it is a nice protection for the motor in case of incidental drops. However, they actually apologized and explained Continue reading >>

Ordering And Billing | Eshop Support - Medtronic Diabetes Uk

Ordering And Billing | Eshop Support - Medtronic Diabetes Uk

Related Supplies (IV Preps, tape, pump batteries) *Please be aware, if you would like to self-fund Continuous Glucose Monitoring, confirmation from your health care provider agreeing to support your care is still needed. Please contact your Hospital to discuss before ordering goods. If you are looking for a product but you cannot find it our online product catalogue, please contact us and we will be happy to discuss your requirements. How long does it take to set up an account? If you are a new customer, our turnaround time to set up your account is 2-3 business days from the moment we have received the funding account registration form from your healthcare provider. Do you have questions regarding your funded account? Call us at +44 (0)1923 202 564 Monday through Friday from 8:30 AM 5:00 PM GMT. Changing doctor / Change in your prescription? If you change doctors or your prescription changes, please let us know so we can update your records. Call +44 (0)1923 202 531 Monday through Friday from 8:30 am 5:30 pm GMT. Please allow up to 3 days for your supply orders to be processed. During this time we will verify your funding to ensure proper billing before your order is shipped. All online orders will be shipped free of charge with TNT 2 Day delivery. In case of emergency, please call +44 (0)1923 205 167 and select option 1 Monday through Friday from 8:30 am 5:30 pm GMT to speak to a Customer Service Representative about your options. Check the status of your order 24 hours a day by signing in to your personal account on the Store. Once you have signed in, click on the Order History tab. If you have recent orders placed you will see a table with all of the important information. To locate your status, view the Order Status which will list a brief description. If you purc Continue reading >>

Contact Us

Contact Us

We ask for full contact information only to consult your Medtronic records when replying to your question. We never share your contact information. Please note: We will respond to your comments or inquiry via email or telephone. Our email response will include your first and last names and will repeat your message to us, which could include personal information about your health. If this is a cause for concern, please call Medtronic Patient Services instead of submitting this form. For more information on how we safeguard your data, please review our privacy policy . Please note: We will respond to your comments or inquiry via email or telephone. Our email response will include your first and last names and will repeat your message to us, which could include personal information about your health. If this is a cause for concern, please call Medtronic Patient Services instead of submitting this form. For more information on how we safeguard your data, please review our privacy policy . Continue reading >>

Review: Medtronic’s Minimed 630g Insulin Pump

Review: Medtronic’s Minimed 630g Insulin Pump

I have used the Minimed 630G Insulin Pump System by Medtronic for the past 30 days. This review is my opinion of the pump, both positive and negative. I have used insulin pumps since I got my first Disetronic H-Tron V-100 in 1994. I got a Minimed 506 pump in 1998 and have been a fan of the Minimed/Medtronic pumps since. Until now. Minimed 630G Insulin Pump System The Minimed 630G Insulin Pump System comes with the pump, the CGM transmitter, and a Contour Next Link 2.4 blood glucose meter. The three devices work well together, once set up right. Medtronic also has an early access program. This lets you buy the Minimed 630G now, and upgrade to the upcoming Minimed 670G in spring of 2017. Receiving the Pump The 630G Pump comes in several boxes. The pump comes in an 8″x10″x2.25″ box that has the pump and several small items like clips, batteries, a manual, and a quick start guide. Another box of the same size has the Contour Next Link 2.4 meter. A second box arrived a few days later with the infusion sets and reservoirs, followed by another box a few days later with the CGM sensors. I got another box a week later with the CGM transmitter. In the past, the local Medtronic trainer would call me to train me on using the pump, with a request not to use it before the training. I normally ignore this request, since I have used Minimed pumps for so long. I do go to these trainings every once in a while, but I was never contact this time. Unusual, considering how new this version of the pump is. Even so, the pump was fairly easy to set up. I also got a pile of 8.5″x11″ manuals. One was a “previous pump users manual” and one was a “pump users manual’. There was a large manual in the box that had everything in it. And another “how to use the CGM” manual. Quite d Continue reading >>

More in diabetes